Ireland out of intensive care, but still looks sickly

Despite exiting its bail-out programme, Ireland still has a long way to go.

The announcement that Ireland has officially exited the €85bn bail-out programme set up by the European Union, European Central Bank and International Monetary Fund at the height of the eurozone crisis "is reason to begin to hope again", says Fergus Finlay in the Irish Examiner.

Yet this doesn't mean that all Ireland's struggles are behind it, says Henry Chu in the Los Angeles Times. Yes, the country has already shown it can once again borrow at commercial interest rates and has built up enough of a reserve to fund itself until 2015 in case markets experience any further turbulence in the next few months.

But "official relief at the end of Ireland's reliance on emergency loans is tempered by the fact that it will continue to face deep government cuts in order to close a yawning budget gap and pay off its debt"; the debt-to-GDP ratio remains an unnerving 124%.

That might be less of an issue if the economy was springing back to life robustly, but Ireland continues to face "significant economic challenges", according to Christine Largarde, the IMF's managing director.

Chief among these is tackling unemployment, especially among the young.Around a quarter of those aged under 25 are jobless, even after significant numbers have left the country in search of better prospects.

Meanwhile, bank lending remains weak and promised structural reforms have been implemented piecemeal at best, says The Economist. Realistically, "Ireland is almost as far away as ever from a clean bill of economic health".

Recommended

How the Covid-19 vaccine crisis is putting the EU in danger
EU Economy

How the Covid-19 vaccine crisis is putting the EU in danger

The botched coronavirus vaccine campaign will cause long-term harm to the EU's economy, says Matthew Lynn.
4 Apr 2021
How the vaccine wars will harm us all
Global Economy

How the vaccine wars will harm us all

Grabbing and hoarding vaccine supplies, or even manufacturing one’s own, might seem to make sense for a state in an emergency. But the damage done to …
27 Mar 2021
The European Central Bank fumbles its way towards yield curve control
EU Economy

The European Central Bank fumbles its way towards yield curve control

The EU’s economic recovery is faltering, but its bond yields keep rising. That makes things tricky for the European Central Bank, says John Stepek. He…
12 Mar 2021
Vexing vaccine delays hit drug firms
Biotech stocks

Vexing vaccine delays hit drug firms

AstraZeneca and Pfizer are being attacked by the EU over what it claims are delays in delivering the Covid vaccine.
28 Jan 2021

Most Popular

“Joke” cryptocurrency dogecoin goes to the moon. What’s going on?
Bitcoin

“Joke” cryptocurrency dogecoin goes to the moon. What’s going on?

Dogecoin – a cryptocurrency created as a joke – has risen by more than 9,000% this year alone. Saloni Sardana looks at how something that began as an …
19 Apr 2021
Lab-grown meat: how “moo’s law” will drive innovation
Soft commodities

Lab-grown meat: how “moo’s law” will drive innovation

Jim Mellon and Anthony Chow, co-founders of Aim-listed Agronomics, explain why they believe that “cellular agriculture” will benefit from massive long…
16 Apr 2021
The bitcoin bubble will burst: here’s how to play it
Bitcoin

The bitcoin bubble will burst: here’s how to play it

The cryptocurrency’s price has soared far beyond its fundamentals, says Matthew Partridge. Here, he looks at how to short bitcoin.
12 Apr 2021